133 Linglestown RoadBy Tony Saavedra
The Orange County Register
Published March 11, 2011
Click Here to Read the Article
Interesting News & Links From The Internet
Fatal Overdoses Were Fueled By Prescription Drugs
A Sugared Pill
By Andrew Jack
The Financial Times
Published March 8, 2011
AstraZeneca Pays $520 Million to Settle Seroquel Whistleblower Claims
AstraZeneca has agreed to pay $520 million in civil fines, penalties and damages to settle allegations that the company defrauded Medicare, Medicaid and other government-funded programs in connection with its marketing and promotional practices for the blockbuster atypical antipsychotic Seroquel.
Pfizer Pays $2 Billion to Settle Off-Label Marketing Case
Pfizer, Inc. has agreed to plead guilty to criminal conduct and to pay more than $2 billion in criminal and civil fines, penalties and damages to settle allegations made in multiple whistleblower lawsuits that the pharmaceutical giant defrauded Medicare, Medicaid and other government-funded health care programs
U.S. Attorney Announces First Settlement Involving Psychiatric Residential Treatment Facilities
U.S. Attorney Announces First Settlement Involving Psychiatric Residential Treatment Facilities in connection with billing of the Medicaid program for servies to children and adolescents in 2005 at Southwood's three Psychiatric Residential Treatment Facilities (PRTFs):
Narrowing the 'Credibility Gap'
Letter to the Editor by Stefan P Kruszewski, M.D.
Psychiatric News October 21, 2005
Volume 40 Number 20 Page 29
http://psychnews.psychiatryonline.org/newsarticle.aspx?articleid=109419
In his July 1 "From the President" column, APA President Steven Sharfstein, M.D., addressed some of the economic issues that plague psychiatry, such as losing ground in reimbursements with a decrease in expenditures, as a percentage of total health care dollars, from 8.2 percent in 1991 to 7.6 percent in 2001. The problems that plagued psychiatric reimbursement 20 years ago have grown worse. As Dr. Sharfstein noted, the cost shift to states' fee-for-service and managed Medicaid programs have become primary payers—and poor ones at that. With imminent cutbacks amid Medicaid financial shortfalls, that payer system continues to implode.
